Johanna ter Burg

Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL

Marco V. Haselager, Karoline Kielbassa, Johanna ter Burg et al. · Blood · 2020 · 116 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia

Rachel Thijssen, Johanna ter Burg, Brett Garrick et al. · Blood · 2016 · 70 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

Functional disparities among BCL-2 members in tonsillar and leukemic B-cell subsets assessed by BH3-mimetic profiling

Victor Peperzak, Erik Slinger, Johanna ter Burg et al. · Cell Death and Differentiation · 2016 · 31 citations · Full text

Life Sciences, Cell Biology, Oncology +16

The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

Rachel Thijssen, Johanna ter Burg, Gregor G. W. van Bochove et al. · Leukemia · 2015 · 21 citations · Full text

Medicine, Cell Biology, Pharmacology +15